Advertisement

28 Large-Scale Ex Vivo Expansion of Human Megakaryocytes for Clinical Use

  • Phil Lefebvre
  • Isaac Cohen
Protocol
  • 379 Downloads
Part of the Methods in Molecular Biology™ book series (MIMB, volume 215)

Abstract

This chapter will describe a method used to produce human megakaryocytes in vitro (see Fig. 1), in high yield, for a clinical product to supplement progenitor cell transplants. Producing significant numbers of megakaryocytes from human progenitor cells requires specific combinations of cytokines to promote their proliferation and maturation in vitro. Thrombopoietin (TPO) is the primary regulator of megakaryocytopoiesis (1-6). Other cytokines, including interleukin-3 (IL-3), IL-6, IL-11, stem cell factor (SCF; also known as kit- ligand), and granulocyte-macrophage colony stimulating factor (GM-CSF) are also capable of promoting megakaryocytopoiesis and will synergize with TPO to increase megakaryocyte proliferation (reviewed in ref. 7).

Keywords

Allogeneic Blood Transfusion Human Megakaryocyte Mature Megakaryocyte Human Progenitor Cell Megakaryocyte Proliferation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Bartley, T. D., Bogenberger, J., Hunt, P., Li, Y. S., Lu, H. S., Martin, F., et al. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77(7), 1117–1124.PubMedCrossRefGoogle Scholar
  2. 2.
    de Sauvage, F. J., Hass, P. E., Spencer, S. D., Malloy, B. E., Gurney, A. L., Spencer, S. A., et al. (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369(6481), 533–538.PubMedCrossRefGoogle Scholar
  3. 3.
    Kaushansky, K., Lok, S., Holly, R. D., Broudy, V. C., Lin, N., Bailey, M. C.,et al. (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 369(6481), 568–571.PubMedCrossRefGoogle Scholar
  4. 4.
    Kuter, D. J., Beeler, D. L., and Rosenberg, R. D. (1994) The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc. Natl. Acad. Sci. USA 91(23), 11,104–11,108.PubMedCrossRefGoogle Scholar
  5. 5.
    Lok, S. and Foster, D. C. (1994) The structure, biology and potential therapeutic applications of recombinant thrombopoietin. Stem Cells 12(6), 586–598.PubMedCrossRefGoogle Scholar
  6. 6.
    Wendling, F., Maraskovsky, E., Debili, N., Florindo, C., Teepe, M., Titeux, M.,et al. (1994) cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369(6481), 571–574.PubMedCrossRefGoogle Scholar
  7. 7.
    Hoffman, R. (1997) The role of other hemopoietic growth factors and the marrow microenvironment in megakaryocytopoiesis, in Thrombopoiesis and Thrombopoi-etins: Molecular, Cellular, Preclinical, and Clinical Biology (Kuter, D. J., Hunt, P., Sheridan, W., and Zucker-Franklin, D., eds.), Humana, Totowa, NJ, pp. 165–178.Google Scholar
  8. 8.
    Zauli, G., Vitale, M., Falcieri, E., Gibellini, D., Bassini, A., Celeghini, C., et al. (1997) In vitro senescence and apoptotic cell death of human megakaryocytes. Blood 90(6), 2234–2243.PubMedGoogle Scholar
  9. 9.
    Lefebvre, P., Winter, J. N., Rademaker, A. W., Goolsby, C., and Cohen, I. (1997) In vitro production of megakaryocytes from PIXY321 versus GM-CSF-mobilized peripheral blood progenitor cells. Stem Cells 15(2), 112–118.PubMedCrossRefGoogle Scholar
  10. 10.
    Lefebvre, P., Winter, J. N., Kahn, L. E., Giri, J. G., and Cohen, I. (1999) Mega-karyocyte ex vivo expansion potential of three hematopoietic sources in serum and serum-free medium. J. Hematother. 8(2), 199–208.PubMedCrossRefGoogle Scholar
  11. 11.
    Bertolini, F., Battaglia, M., Pedrazzoli, P., Da Prada, G. A., Lanza, A., Soligo, D., et al. (1997) Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 89(8), 2679–2688.PubMedGoogle Scholar
  12. 12.
    Schattner, M., Lefebvre, P., Mingolelli, S. S., Goolsby, C. L., Rademaker, A., White, J. G., et al. (1996) Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells 14(2), 207–214.PubMedCrossRefGoogle Scholar
  13. 13.
    van den Oudenrijn, S., de Haas, M., Calafat, J., van der Schoot, C. E., and von dem Borne, A. E. G. K. (1999) A combination of megakaryocyte growth and development factor and interleukin-1 is sufficient to culture large numbers of megakaryocytic progenitors and megakaryocytes for 14. transfusion purposes. Br. J. Haematol. 106(2), 553–563.PubMedCrossRefGoogle Scholar
  14. 14.
    Lefebvre, P., Winter, J. N., Meng, Y. R., and Cohen, I. (2000) Ex vivo expansion of early and late megakaryocyte progenitors. J. Hematother. Stem Cell Res. 9(6), 913–921.PubMedCrossRefGoogle Scholar
  15. 15.
    Levin, J., Levin, F. C., Penington, D. G., and Metcalf, D. (1981) Measurement of ploidy distribution in megakaryocyte colonies obtained from culture: with studies of the effects of thrombocytopenia. Blood 57(2), 287–297.PubMedGoogle Scholar
  16. 16.
    Guerriero, R., Mattia, G., Testa, U., Chelucci, C., Macioce, G., Casella, I., et al. (2001) Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood 97(9), 2587–2595.PubMedCrossRefGoogle Scholar
  17. 17.
    Mitjavila, M. T., Vinci, G., Villeval, J. L., Kieffer, N., Henri, A., Testa, U., et al. (1988) Human platelet alpha granules contain a nonspecific inhibitor of megakaryocyte colony formation: its relationship to type beta transforming growth factor (TGF-beta). J. Cell. Physiol. 134(1), 93–100.PubMedCrossRefGoogle Scholar
  18. 18.
    Gewirtz, A. M., Calabretta, B., Rucinski, B., Niewiarowski, S., and Xu, W. Y. (1989) Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J. Clin. Invest. 83(5), 1477–1486.PubMedCrossRefGoogle Scholar
  19. 19.
    Abgrall, J. F., Han, Z. C., Sensebe, L., Le Gall, G., Guern, G., Renard, I., et al.(1991) Inhibitory effect of highly purified human platelet beta-thromboglobulin on in vitro human megakaryocyte colony formation. Exp. Hematol. 19(3), 202–205.PubMedGoogle Scholar
  20. 20.
    Dercksen, M. W., Weimar, I. S., Richel, D. J., Breton-Gorius, J., Vainchenker, W., Slaper-Cortenbach, C. M., et al. (1995) The value of flow cytometric analysis of platelet glycoprotein expression of CD34+cells measured under conditions that prevent P-selectin-mediated binding of platelets. Blood 86(10), 3771–3782.PubMedGoogle Scholar
  21. 21.
    de Wynter, E. A., Coutinho, L. H., Pei, X., Marsh, J. C., Hows, J., Luft, T., et al. (1995) Comparison of purity and enrichment of CD34+cells from bone marrow,umbilical cord and peripheral blood (primed for apheresis) using five separation systems. Stem Cells 13(5), 524–532.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2003

Authors and Affiliations

  • Phil Lefebvre
    • 1
  • Isaac Cohen
    • 1
  1. 1.Department of MedicineNorthwestern UniversityChicago

Personalised recommendations